Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells

被引:39
作者
Fanaee-Danesh, Elham [1 ]
Gali, Chaitanya Chakravarthi [1 ]
Tadic, Jelena [2 ]
Zandl-Lang, Martina [1 ]
Kober, Alexandra Carmen [1 ]
Roca Agujetas, Vicente [3 ]
de Dios, Cristina [3 ,4 ]
Tam-Amersdorfer, Carmen [1 ]
Stracke, Anika [1 ]
Albrecher, Nicole Maria [1 ]
Manavalan, Anil Paul Chirackal [1 ]
Reiter, Marielies [1 ]
Sun, Yidan [1 ]
Colell, Anna [3 ]
Madeo, Frank [2 ,5 ]
Malle, Ernst [6 ]
Panzenboeck, Ute [1 ]
机构
[1] Med Univ Graz, Otto Loewi Res Ctr, Div Immunol & Pathophysiol, Heinrichstr 31a, A-8010 Graz, Austria
[2] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria
[3] CSIC, Dept Cell Death & Proliferat, Inst Invest Biomed Barcelona, IDIBAPS,Ctr Invest Biomed Red Enfermedades Neurod, Barcelona, Spain
[4] Univ Barcelona, Fac Med, Dept Biomed, Barcelona, Spain
[5] BioTechMed Graz, Graz, Austria
[6] Med Univ Graz, Gottfried Schatz Res Ctr, Div Mol Biol & Biochem, Graz, Austria
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2019年 / 1865卷 / 09期
基金
奥地利科学基金会;
关键词
Blood-brain barrier; Alzheimer's disease; APP processing; ABCA1; Cholesterol efflux; LRP-1; HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; A-BETA; APOLIPOPROTEIN-E; MOUSE MODEL; IN-VITRO; OXIDATIVE STRESS; STEROL TRANSPORT; SEX-DIFFERENCES; PEPTIDE;
D O I
10.1016/j.bbadis.2019.04.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pathogenesis of Alzheimer's disease (AD) is characterized by overproduction, impaired clearance, and deposition of amyloid-beta peptides (A beta) and connected to cholesterol homeostasis. Since the blood-brain barrier (BBB) is involved in these processes, we investigated effects of the retinoid X receptor agonist, bexarotene (Bex), and the peroxisome proliferator-activated receptor a agonist and antioxidant, astaxanthin (Asx), on pathways of cellular cholesterol metabolism, amyloid precursor protein processing/A beta production and transfer at the BBB in vitro using primary porcine brain capillary endothelial cells (pBCEC), and in 3xTg AD mice. Asx/Bex down regulated transcription/activity of amyloidogenic BACE1 and reduced A beta oligomers and similar to 80 kDa intracellular 6E10-reactive APP/A beta species, while upregulating non-amyloidogenic ADAM10 and soluble (s)APP alpha production in pBCEC. Asx/Bex enhanced A beta clearance to the apical/plasma compartment of the in vitro BBB model. Asx/Bex increased expression levels of ABCA1, LRP1, and/or APOA-I. Asx/Bex promoted cholesterol efflux, partly via PPAR alpha/RXR activation, while cholesterol biosynthesis/esterification was suppressed. Silencing of LRP-1 or inhibition of ABCA1 by probucol reversed Asx/Bex-mediated effects on levels of APP/A beta species in pBCEC. Murine (m)BCEC isolated from 3xTg AD mice treated with Bex revealed elevated expression of APOE and ABCA1. Asx/Bex reduced BACE1 and increased LRP-1 expression in mBCEC from 3xTg AD mice when compared to vehicle-treated or non-Tg treated mice. In parallel, Asx/Bex reduced levels of A beta oligomers in mBCEC and A beta species in brain soluble and insoluble fractions of 3xTg AD mice. Our results suggest that both agonists exert beneficial effects at the BBB by balancing cholesterol homeostasis and enhancing clearance of A beta from cerebrovascular endothelial cells.
引用
收藏
页码:2224 / 2245
页数:22
相关论文
共 115 条
[1]   Astaxanthin ameliorates aluminum chloride-induced spatial memory impairment and neuronal oxidative stress in mice [J].
Al-Amin, Md Mamun ;
Reza, Hasan Mahmud ;
Saadi, Hasan Mahmud ;
Mahmud, Waich ;
Ibrahim, Abdirahman Adam ;
Alam, Musrura Mefta ;
Kabir, Nadia ;
Saifullah, A. R. M. ;
Tropa, Sarjana Tarannum ;
Quddus, A. H. M. Ruhul .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 777 :60-69
[2]   Therapeutics of Alzheimer's disease: Past, present and future [J].
Anand, R. ;
Gill, Kiran Dip ;
Mahdi, Abbas Ali .
NEUROPHARMACOLOGY, 2014, 76 :27-50
[3]   Stimulation of the Retinoid X Receptor Facilitates Beta-Amyloid Clearance Across the Blood-Brain Barrier [J].
Bachmeier, Corbin ;
Beaulieu-Abdelahad, David ;
Crawford, Fiona ;
Mullan, Michael ;
Paris, Daniel .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 49 (02) :270-276
[4]   Sex differences in the clinical manifestations of Alzheimer disease pathology [J].
Barnes, LL ;
Wilson, RS ;
Bienias, JL ;
Schneider, JA ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (06) :685-691
[5]   Reagent or myeloperoxidase-generated hypochlorite affects discrete regions in lipid-free and lipid-associated human apolipoprotein A-1 [J].
Bergt, C ;
Oettl, K ;
Keller, W ;
Andreae, F ;
Leis, HJ ;
Malle, E ;
Sattler, WG .
BIOCHEMICAL JOURNAL, 2000, 346 (02) :345-354
[6]  
BOWMAN PD, 1981, IN VITRO CELL DEV B, V17, P353
[7]   Sex differences in β-amyloid accumulation in 3xTg-AD mice: Role of neonatal sex steroid hormone exposure [J].
Carroll, Jenna C. ;
Rosario, Emily R. ;
Kreimer, Sara ;
Villamagna, Angela ;
Gentzschein, Elisabet ;
Stanczyk, Frank Z. ;
Pike, Christian J. .
BRAIN RESEARCH, 2010, 1366 :233-245
[8]   Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease [J].
Casali, Brad T. ;
Reed-Geaghan, Erin G. ;
Landreth, Gary E. .
JOURNAL OF NEUROINFLAMMATION, 2018, 15
[9]  
Casali Brad T, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.1787
[10]   Oxidative stress and the amyloid beta peptide in Alzheimer's disease [J].
Cheignon, C. ;
Tomas, M. ;
Bonnefont-Rousselot, D. ;
Faller, P. ;
Hureau, C. ;
Collin, F. .
REDOX BIOLOGY, 2018, 14 :450-464